research Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss
Low-dose oral minoxidil may help with hair loss, but more research is needed.
Search
for
Sort by
Research
870-900 / 1000+ results research Light-based therapies in the treatment of alopecia
Light-based therapies show promise as safe treatments for hair loss.
research Haircare practices and scarring alopecia: a survey study
Chemical treatments and tight hairstyles may lead to earlier hair loss.
research Outcomes of Androgenetic Alopecia Treated with Dutasteride Mesotherapy: A Case Series
Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.
research Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management
Both treatment combinations improved hair growth similarly and were safe.
research 48799 Defining Perceptual Thresholds for Hair Density Changes: A Study of Dermatologist Perceptions
Dermatologists can detect smaller hair density changes than previously thought.
research Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium
Low-dose oral minoxidil is effective and safe for treating androgenetic alopecia.
research 172 The impact of overlapping topical and oral minoxidil to combat temporary hair shedding during oral minoxidil initiation
Using both topical and oral minoxidil does not reduce hair shedding.
research 180 Impact of underlying medical conditions and medications on edema development in alopecia patients receiving low-dose oral minoxidil (LDOM)
Low-dose oral minoxidil is safe for alopecia patients, even those prone to edema.
research Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases
Corticosteroid injections for hair loss may cause eye problems, so caution is needed.
research BH04 A global survey to assess practice of laboratory testing in alopecia areata by hair specialists
Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.
research Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
Baricitinib may not always prevent relapse in alopecia areata.
research GLP‐1 agonists and hair loss: a call for further investigation
More research is needed to understand if GLP-1 agonists affect hair health.
research Navigating Diagnostic Uncertainty: Frontal Fibrosing Alopecia Versus Keratosis Pilaris Atrophicans Faciei With Genetic Testing Insights
Genetic testing can help diagnose skin conditions but needs more research for full effectiveness.
research Oral minoxidil and the exacerbation of alcohol hangover symptoms
Oral minoxidil may worsen hangover symptoms when combined with alcohol.
research Scalp trauma in lichen planopilaris: Case reports of disease progression from fire fighter helmet use
Wearing fire helmets may worsen lichen planopilaris in firefighters.
research Response to Nathalie Y. Ly and colleagues “Medical and procedural treatment of androgenetic alopecia - Where are we?”
research Combating “Dread Shed”: The Impact of Overlapping Topical and Oral Minoxidil on Temporary Hair Shedding During Oral Minoxidil Initiation
Using both topical and oral minoxidil doesn't significantly reduce temporary hair shedding.
research Response to “Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study”
research Examining the Uncertainties Surrounding Exosome Therapy in Androgenetic Alopecia: A Call for Evidence-Based Practice.
The document concludes that more standardized research is needed to understand exosome therapy's safety and effectiveness for hair loss treatment.
research Platelet-Rich Plasma Applications, The Past 5 Years: A Review Article
PRP can reduce pain and improve function, but more standardized research is needed.
research Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.
research Evaluating the role of COVID-19 vaccines in the landscape of medication-induced alopecia areata
The document concludes that more research is needed to confirm if COVID-19 vaccines cause a type of hair loss called alopecia areata.
research Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
People with common hair loss conditions may have a higher risk of heart disease and related health issues.
research When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.
research 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata
The document's conclusion cannot be provided because the content is not available.
research 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.
research Sentiment analysis and natural language processing using Reddit data to evaluate patient opinions on hair loss therapeutics (Preprint)
People on Reddit generally have positive opinions about hair loss treatments.
research Intradermal Delivery of Alopecia Therapeutics: Current State and Future Prospects
New injection methods for hair loss treatment show promise but need more research.
research A case of cutis verticis gyrata developing in a patient with primary scarring alopecia: A unique presentation of a rare disorder
A rare scalp condition, cutis verticis gyrata, was found in a woman with primary scarring alopecia.